Suppr超能文献

套细胞淋巴瘤的母细胞样变异型和常见变异型表现出不同的免疫表型和间期荧光原位杂交特征。

Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.

作者信息

Parrens M, Belaud-Rotureau M-A, Fitoussi O, Carerre N, Bouabdallah K, Marit G, Dubus P, de Mascarel A, Merlio J-P

机构信息

Department of Pathology and Tumour Biology, CHU Bordeaux and Equipe 2406, University of Bordeaux 2, Bordeaux, France.

出版信息

Histopathology. 2006 Mar;48(4):353-62. doi: 10.1111/j.1365-2559.2005.02323.x.

Abstract

AIMS

The recognition of blastoid variant (BV) of mantle cell lymphoma (MCL) is based on morphological criteria. Our aim was to analyse 18 MCL cases including four BV-MCL for their clinicopathological features, proliferation index, cyclin D1 and CDK4 expression and interphase fluorescence in-situ hybridization (FISH) pattern.

METHODS AND RESULTS

BV-MCL versus common MCL was characterized by a shorter overall duration of response after first-line therapy (11 months versus 28 months) and shorter overall survival (20 months versus 42 months). Interphase FISH showed a t(11;14) fusion pattern in all MCL tested cases. However, the four blastoid cases were characterized by extra copies of CCND1 signals. Using additional probes of chromosomes 11, 18, 21, these signals were shown to be the result of hypotetraploidy and not of a specific amplification of the normal or the translocated CCND1 allele. Moreover, the BV-MCL cases were characterized by a combined high percentage of cells expressing cyclin D1 and/or CDK4 with a proliferation (MIB-1-Ki67) index above 50%. Such features allowed the recognition of areas of large cell transformation in the case of secondary BV-MCL.

CONCLUSIONS

Since distinction between BV and common MCL is of clinical relevance, our data underline the need to add phenotypic and cytogenetic criteria to cytomorphology for a better recognition of BV-MCL.

摘要

目的

套细胞淋巴瘤(MCL)母细胞样变异型(BV)的识别基于形态学标准。我们的目的是分析18例MCL病例,包括4例BV-MCL,以了解其临床病理特征、增殖指数、细胞周期蛋白D1和细胞周期蛋白依赖性激酶4(CDK4)表达以及间期荧光原位杂交(FISH)模式。

方法与结果

BV-MCL与普通MCL相比,一线治疗后的总缓解持续时间较短(11个月对28个月),总生存期较短(20个月对42个月)。间期FISH显示,所有检测的MCL病例均有t(11;14)融合模式。然而,4例母细胞样病例的特征是CCND1信号有额外拷贝。使用11号、18号、21号染色体的额外探针,这些信号显示是亚四倍体的结果,而非正常或易位的CCND1等位基因的特异性扩增。此外,BV-MCL病例的特征是,表达细胞周期蛋白D1和/或CDK4的细胞比例较高,且增殖(MIB-1-Ki67)指数高于50%。这些特征有助于识别继发性BV-MCL病例中的大细胞转化区域。

结论

由于BV与普通MCL的区分具有临床相关性,我们的数据强调,为了更好地识别BV-MCL,除细胞形态学外,还需增加表型和细胞遗传学标准。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验